Monash University researchers have developed a world-first personalised app to improve the sleep and mood of vital shift workers.
During the pandemic shift workers kept the nation functioning. Our healthcare shift workers helped many of us survive its deadly effects. We know from research and our own experience the critical role sleep plays in maintaining good mental and physical health.
Earlier this year, Turner Institute for Brain and Mental Health researchers developed SleepSync, the world’s first app that personalises sleep-wake cycles for shift workers to improve their sleep and overall mood.
The research, led by Dr Jade Murray, was published in the journal, Digital Health. Australian Health Journal met with Dr Murray to hear how the application has evolved and been used in personalisation of sleep habits for health care shift workforce.
It saw 27 shift workers trial the app over a two-week period; mainly intensive care and emergency department nurses at high risk of shift work disorder, commonly experienced as insomnia and excessive sleepiness.
SleepSync improved total sleep time, ability to fall asleep, sleep quality and perception of recovery on days off. With the app considering each individual’s daily routine, 70 percent reported it was easier to fall asleep, and more than 80 per cent reported better quality sleep. Participants slept an average 29 minutes longer each night.
“SleepSync aims to aid behavioural change and provide practical advice to shift workers by providing personalised sleep scheduling recommendations and education,” Dr Murray said.
“This has the potential to improve shift workers’ health and wellbeing and how they function day to day. It also has the potential for development and integration with wearable devices, such as smartwatches, and further help minimise the health costs associated with shift work to society.”
SleepSync, a mobile phone app, is unique because it is entirely tailored to the individual user by:
► incorporating a calendar for work and personal commitments
► providing biologically viable recommendations for sleep timing that account for work and social obligations based on the information users enter into the calendar, such as work shifts and important personal activities
► daily logging of actual sleep/wake times and mood
Users receive a ‘recovery score’ based on their level of adherence with the recommended sleep times.
Dr Murray said work hours outside the 9 to 5 regime play havoc with the body’s circadian clock. “Shift workers report an increased functional impact of sleep disturbance and misalignment, including impaired alertness and increased sleepiness during wakefulness compared to the general population,” she said.
“Shift workers are also at greater risk of a range of long-term adverse health consequences such as gastrointestinal problems, cardiovascular disease, mood disorders and cancer, as well as the short term increase in the risk of errors, accidents and injuries.”
To date, helping a shift worker to sleep well has largely relied on workplace interventions such as adjusting workplace lighting, scheduled workplace napping, sleep hygiene programs, wellness programs and workplace fatigue management programs.
Co-author Dr Tracey Sletten, of the Turner Institute, said individual workers needed evidence-backed ways to optimise their sleep around their work schedule. “Each person has different underlying biology and specific work patterns, which need to be accommodated in a personalised schedule to help them sleep better,” Dr Sletten said.
Dr Sletten said 67 percent of participants reported how influential SleepSync was for modifying their behaviour and habits, while 82 per cent found the app easy to incorporate into their daily lives. “They also reported improvements in mood (depression, anxiety and stress), insomnia symptom severity, sleep hygiene and sleep-related daytime impairments,” she said.
You Might also like
-
Health Minister appoints Chair to National One Stop Shop Program
The Australian Government has appointed Emeritus Professor Ian Chubb AC, FAA FTSE to lead key reforms as Chair of the Inter-Governmental Policy Reform Group (IGPRG) for health and medical research, including clinical trials.
Minister for Health and Aged Care, The Hon Mark Butler MP on the selection and appointment said, “Professor Chubb has dedicated his career to improving health and medical research and education in this county and I am pleased he has agreed to share his knowledge and experience through the IGPRG.
-
Continuing education program leads to better conversations
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.